GO:0003277 apoptotic process involved in endocardial cushion morphogenesis: Heart Valve Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003277 describes the programmed cell death that shapes the endocardial cushion, the embryonic tissue that gives rise to heart septa and valves.
• Apoptosis in the endocardial cushion is essential for normal cardiac septation and valve formation, and its disruption is linked to congenital heart defects.
• TGF-beta signaling, including ALK5 and TGF-beta2, regulates cushion remodeling and apoptosis during heart development.
• Bone morphogenetic proteins (BMPs) are expressed in the endocardial cushions and influence their development and remodeling.
• Maternal diabetes can disturb TGF-beta signaling and increase the risk of cardiac malformations, including outflow tract defects.
• Studying GO:0003277 requires combining developmental models, apoptosis assays, and CRISPR-based gene editing to test causal roles of candidate genes.
Description
The endocardial cushion is a specialized region of mesenchymal cells in the developing heart that will give rise to the heart septa and valves. The apoptotic process involved in endocardial cushion morphogenesis (GO:0003277) refers to any programmed cell death that contributes to the shaping of this cushion. This process is critical for normal cardiac development, as it helps remodel the cushion into mature valve leaflets and septal structures. Disruptions in this apoptotic program have been associated with congenital heart defects, including valve and septal abnormalities. Understanding the molecular regulation of apoptosis in the endocardial cushion is therefore essential for developmental biologists and clinicians studying heart malformations. Key signaling pathways, such as TGF-beta and BMP, have been shown to modulate cushion development and remodeling. This article provides a research-grade overview of GO:0003277, covering its definition, mechanisms, key genes, disease relevance, and modern research methods including CRISPR-based models.
apoptotic process involved in endocardial cushion morphogenesis At A Glance
| GO ID | GO:0003277 |
|---|---|
| GO term | apoptotic process involved in endocardial cushion morphogenesis |
| Ontology | biological_process |
| Synonym | apoptosis involved in endocardial cushion morphogenesis |
| Definition | Any apoptotic process that contributes to the shaping of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves. |
| Major function | Programmed cell death that remodels the endocardial cushion during heart development. |
| Related processes | Cardiac septation, valve formation, TGF-beta signaling, BMP signaling. |
| Disease relevance | Congenital heart defects, valve anomalies, septal defects. |
What Is GO:0003277?
GO:0003277, apoptotic process involved in endocardial cushion morphogenesis, is defined as any apoptotic process that contributes to the shaping of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves. In simpler terms, it is the programmed cell death that helps sculpt the embryonic heart cushion into the structures that separate the heart chambers and form the valves.
Why Is apoptotic process involved in endocardial cushion morphogenesis Important in Cell Biology?
Apoptosis in the endocardial cushion is a fundamental developmental process that ensures proper heart septation and valve formation. Without precise regulation of cell death, the cushion may fail to remodel correctly, leading to congenital heart defects such as ventricular septal defects or valve stenosis. Understanding GO:0003277 helps researchers identify the molecular players and signaling pathways that control this process, offering insights into the etiology of congenital heart disease and potential therapeutic targets.
• Essential for normal cardiac septation and valve formation.
• Disruption leads to congenital heart defects, including septal and valve anomalies.
• Regulated by TGF-beta signaling, including ALK5 and TGF-beta2.
• BMPs are expressed in endocardial cushions and influence their development.
• Maternal diabetes can alter TGF-beta signaling and increase risk of cardiac malformations.
• Provides a model for studying programmed cell death in development.
• Relevant to tissue engineering and regenerative approaches for heart valves.
• Helps understand the interplay between apoptosis and morphogenesis.
• Potential target for preventing congenital heart defects.
• Requires advanced methods like CRISPR to test gene function.
What Happens During apoptotic process involved in endocardial cushion morphogenesis?
Initiation of apoptosis in the endocardial cushion
In simple terms: Cells in the heart cushion receive signals to die at the right time.
Apoptosis in the endocardial cushion is initiated by developmental cues that trigger programmed cell death in specific regions of the cushion. This process is tightly regulated to ensure that only certain cells are removed to shape the developing heart structures. Signaling pathways such as TGF-beta and BMP are involved in initiating these apoptotic events.
Execution of apoptosis
In simple terms: The dying cells break down and are cleared away.
Once initiated, the apoptotic machinery executes cell death, leading to DNA fragmentation and cellular dismantling. This execution phase is crucial for remodeling the cushion into septa and valves. The clearance of apoptotic cells by phagocytes prevents inflammation and facilitates tissue remodeling.
Remodeling of the endocardial cushion
In simple terms: The cushion is reshaped into heart valves and septa.
Apoptosis contributes to the remodeling of the endocardial cushion by removing excess cells, allowing the remaining tissue to reorganize into mature structures. This remodeling is essential for the formation of the heart septa and valves. TGF-beta2 has been implicated in myocardial remodeling during valve formation.
Regulation by TGF-beta and BMP signaling
In simple terms: Signals from TGF-beta and BMP control when and where cells die.
TGF-beta signaling via ALK5 is critical for heart development and regulates cushion remodeling. BMPs are expressed in the endocardial cushions and modulate their development. Disruption of these pathways can lead to abnormal apoptosis and cardiac malformations.
Key Genes Involved in GO:0003277 apoptotic process involved in endocardial cushion morphogenesis
The following genes and proteins are involved in the apoptotic process during endocardial cushion morphogenesis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB2 | Regulates myocardial remodeling during valve formation | Studied in TGF-beta2 knockout models for valve defects |
| ALK5 | TGF-beta type I receptor; mediates signaling in heart development | Conditional knockout shows cushion defects |
| BMP2 | Expressed in endocardial cushions; influences development | Implicated in cushion morphogenesis |
| BMP4 | Expressed in endocardial cushions; regulates apoptosis | Studied in cushion development |
| YY1 | Transcription factor critical for cardiac morphogenesis | Knockout leads to heart defects |
| SMAD2 | Downstream mediator of TGF-beta signaling | Phosphorylated in cushion cells |
| SMAD3 | Downstream mediator of TGF-beta signaling | Involved in cushion remodeling |
| CASP3 | Executioner caspase in apoptosis | Marker of apoptosis in cushion |
| CASP8 | Initiator caspase in apoptosis | Potential role in cushion apoptosis |
| BAX | Pro-apoptotic Bcl-2 family member | Detected in apoptotic cushion cells |
| BCL2 | Anti-apoptotic protein | Modulates apoptosis in cushion |
| TP53 | Tumor suppressor; can induce apoptosis | May influence cushion apoptosis |
| NOTCH1 | Signaling in valve development | Mutations linked to valve disease |
| GATA4 | Transcription factor in heart development | Regulates cushion genes |
| NKX2-5 | Cardiac transcription factor | Essential for heart morphogenesis |
| VEGFA | Angiogenic factor; may affect cushion | Studied in cushion vascularization |
| HIF1A | Hypoxia-inducible factor | Potential role in cushion remodeling |
How Is apoptotic process involved in endocardial cushion morphogenesis Regulated?
The apoptotic process in the endocardial cushion is regulated by multiple signaling pathways. TGF-beta signaling through ALK5 is essential for cushion remodeling and apoptosis. BMPs, including BMP2 and BMP4, are expressed in the cushions and modulate development. TGF-beta2 has been shown to play a role in myocardial remodeling during valve formation. Additionally, maternal diabetes can alter TGF-beta signaling, leading to cardiac malformations. These pathways converge on downstream effectors such as SMAD proteins and caspases to control cell death.
apoptotic process involved in endocardial cushion morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB2 | Valve defects | TGF-beta2 knockout mouse |
| ALK5 | Cardiac malformations | Conditional ALK5 knockout |
| BMP2 | Cushion defects | BMP2 overexpression/knockout |
| YY1 | Heart morphogenesis defects | YY1 knockout mouse |
| CASP3 | Apoptosis dysregulation | Caspase-3 knockout |
Congenital heart defects
Disruption of apoptosis in the endocardial cushion is associated with congenital heart defects, including ventricular septal defects and valve anomalies. Abnormal TGF-beta signaling has been linked to cardiac malformations in diabetic embryopathy. Understanding these mechanisms may help prevent or treat congenital heart disease.
Diabetic embryopathy
Maternal diabetes can disturb TGF-beta signaling and increase the risk of cardiac outflow tract defects and aortic arch anomalies in offspring. These defects may arise from altered apoptosis during cushion morphogenesis.
Valve disease
Defects in endocardial cushion remodeling can lead to valve stenosis or regurgitation later in life. TGF-beta2 and BMP signaling are implicated in valve formation and remodeling.
From apoptotic process involved in endocardial cushion morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate apoptosis in cushion? | Knockout mouse or CRISPR KO in cell line |
| Does point mutation in gene X affect cushion? | Point mutation knock-in mouse |
| Does overexpression of gene X alter cushion? | Transgenic overexpression |
| Where is gene X expressed during cushion development? | Tagged knock-in reporter |
| Does gene X interact with TGF-beta pathway? | Co-IP or proximity labeling |
| Can CRISPR screen identify novel cushion apoptosis genes? | CRISPR library screening in cardiac progenitors |
How to Study the apoptotic process involved in endocardial cushion morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TUNEL | Apoptotic DNA fragmentation | Detect apoptosis in cushion |
| Cleaved caspase-3 IHC | Caspase-3 activation | Apoptosis marker |
| RNA-seq | Gene expression changes | Identify regulators |
| Proteomics | Protein abundance and modifications | Discover signaling changes |
| Lineage tracing | Cell fate | Track apoptotic cells |
| Confocal imaging | 3D structure | Visualize cushion remodeling |
| CRISPR screen | Gene function | Identify essential genes |
Apoptosis assays
TUNEL staining and cleaved caspase-3 immunohistochemistry are used to detect apoptotic cells in endocardial cushions. These methods allow spatiotemporal analysis of programmed cell death during heart development.
Lineage tracing and imaging
Genetic lineage tracing in mice can reveal the fate of cushion cells undergoing apoptosis. Confocal imaging of whole-mount hearts provides three-dimensional views of cushion remodeling.
Transcriptomics and proteomics
RNA-seq and proteomics can identify genes and proteins differentially expressed during cushion apoptosis. These approaches help uncover novel regulators of GO:0003277.
CRISPR screening
CRISPR library screening in cardiac progenitor cells can identify genes essential for apoptosis during cushion morphogenesis. This unbiased approach accelerates discovery of new players.
How CRISPR Can Be Used to Study GO:0003277 apoptotic process involved in endocardial cushion morphogenesis
Knockout
CRISPR knockout of candidate genes in cardiac progenitor cells or mouse models can test their requirement for apoptosis in the endocardial cushion. For example, knocking out YY1 leads to cardiac morphogenesis defects.
Point Mutation
Introducing point mutations in genes like ALK5 can mimic human variants and assess their impact on cushion apoptosis. This helps distinguish pathogenic from benign variants.
Knock-in
Knock-in of reporter tags (e.g., GFP) into endogenous loci allows visualization of gene expression during cushion development. This can reveal spatiotemporal patterns of apoptotic regulators.
Overexpression
Overexpression of pro-apoptotic genes like BAX or BMPs in the cushion can induce excessive apoptosis and test sufficiency. This complements loss-of-function studies.
How EDITGENE Supports apoptotic process involved in endocardial cushion morphogenesis Research
Researchers studying apoptotic process involved in endocardial cushion morphogenesis-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for apoptotic process involved in endocardial cushion morphogenesis research.
Frequently Asked Questions About apoptotic process involved in endocardial cushion morphogenesis
What is GO:0003277?
GO:0003277 is the Gene Ontology term for apoptotic process involved in endocardial cushion morphogenesis, describing programmed cell death that shapes the embryonic heart cushion.
What genes are involved in apoptotic process involved in endocardial cushion morphogenesis?
Key genes include TGFB2, ALK5, BMP2, BMP4, YY1, and caspases such as CASP3.
Why is apoptosis important in endocardial cushion development?
Apoptosis remodels the cushion into heart septa and valves; its disruption causes congenital heart defects.
How is apoptosis regulated in the endocardial cushion?
TGF-beta and BMP signaling pathways regulate apoptosis in the cushion.
What diseases are linked to defects in endocardial cushion apoptosis?
Congenital heart defects, valve anomalies, and diabetic embryopathy-related cardiac malformations.
What model systems are used to study GO:0003277?
Mouse models, cardiac progenitor cell lines, and CRISPR-based screens are commonly used.
How can CRISPR help study endocardial cushion apoptosis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional testing of candidate genes.
What methods detect apoptosis in the cushion?
TUNEL, cleaved caspase-3 staining, and lineage tracing are standard methods.
Is TGF-beta signaling involved in cushion apoptosis?
Yes, TGF-beta signaling via ALK5 and TGF-beta2 is critical for cushion remodeling and apoptosis.
Can environmental factors affect endocardial cushion apoptosis?
Maternal diabetes can alter TGF-beta signaling and increase risk of cardiac malformations.
Conclusion
GO:0003277, apoptotic process involved in endocardial cushion morphogenesis, is a vital developmental process that ensures proper heart septation and valve formation. Its dysregulation is linked to congenital heart defects and other cardiac anomalies. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate the molecular mechanisms and identify therapeutic targets.
References
- 1. Person AD et al.. 2005. Cell biology of cardiac cushion development.. Int Rev Cytol 243:287-335 PMID: 15797462
- 2. Beketaev I et al.. 2015. Critical role of YY1 in cardiac morphogenesis.. Dev Dyn 244(5):669-80 PMID: 25703143
- 3. Keyes WM et al.. 2003. Expression and function of bone morphogenetic proteins in the development of the embryonic endocardial cushions.. Anat Embryol (Berl) 207(2):135-47 PMID: 12905017
- 4. Sridurongrit S et al.. 2008. Signaling via the Tgf-beta type I receptor Alk5 in heart development.. Dev Biol 322(1):208-18 PMID: 18718461
- 5. Zhao Z. 2010. Cardiac malformations and alteration of TGFbeta signaling system in diabetic embryopathy.. Birth Defects Res B Dev Reprod Toxicol 89(2):97-105 PMID: 20127828
- 6. Molin DG et al.. 2004. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats.. Birth Defects Res A Clin Mol Teratol 70(12):927-38 PMID: 15578651
- 7. Kruithof BP et al.. 2013. Remodeling of the myocardium in early trabeculation and cardiac valve formation; a role for TGFβ2.. Int J Dev Biol 57(11-12):853-63 PMID: 24623077
- 8. Sharma PR et al.. 2004. Spatiotemporal analysis of programmed cell death during mouse cardiac septation.. Anat Rec A Discov Mol Cell Evol Biol 277(2):355-69 PMID: 15052663
